Sheets Smith Wealth Management Adma Biologics, Inc. Transaction History
Sheets Smith Wealth Management
- $832 Million
- Q2 2025
A detailed history of Sheets Smith Wealth Management transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Sheets Smith Wealth Management holds 19,139 shares of ADMA stock, worth $344,693. This represents 0.04% of its overall portfolio holdings.
Number of Shares
19,139Holding current value
$344,693% of portfolio
0.04%Shares
1 transactions
Others Institutions Holding ADMA
# of Institutions
387Shares Held
190MCall Options Held
2.53MPut Options Held
696K-
Black Rock Inc. New York, NY18.6MShares$336 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA16.8MShares$303 Million0.01% of portfolio
-
Invesco Ltd. Atlanta, GA12.9MShares$232 Million0.05% of portfolio
-
State Street Corp Boston, MA11.4MShares$206 Million0.01% of portfolio
-
Geode Capital Management, LLC Boston, MA5.67MShares$102 Million0.01% of portfolio
About ADMA BIOLOGICS, INC.
- Ticker ADMA
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 196,356,992
- Market Cap $3.54B
- Description
- ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...